Hot Products
| Catalog No. | Information |
| CFN94832 | Raddeanoside R8 Raddeanoside R8 is a natural product from Anemone raddeana Regel. |
| CFN90425 | Raffinose After treatment with CVGI, Raffinose family oligosaccharide was hydrolyzed effectively to yield galactose and sucrose. AA-PCD resistance in Raffinose-grown cells occurs with a decrease in both ROS production and cytochrome c release as compared to glucose-grown cells en route to AA-PCD. |
| CFN93555 | Ranaconitine Ranaconitine has cardiotoxicity. |
| CFN96098 | Randaiol Randaiol is a natural product from Magnolia hypoleuca. |
| CFN91138 | Randialic acid B Randialic acid B shows significant cell-protective effects against H2O2-induced H9c2 cardiomyocyte injury. |
| CFN60038 | Rapamycin (Sirolimus) Rapamycin (Sirolimus, AY 22989, NSC-2260804) is a specific mTOR inhibitor with IC50 of ~0.1 nM HEK293 cells. |
| CFN91185 | Rapanone Rapanone is a potential cytotoxic compound, it induced apoptosis in MCF-7 cells mediated by increased ROS production and MMP loss, respectively. Rapanone impairs mitochondrial respiration by inhibiting electron transport chain at Complex III and promotes mitochondrial dysfunction. |
| CFN96896 | Raspberry ketone Raspberry ketone prevents and improves obesity and fatty liver by increasing norepinephrine-induced lipolysis in white adipocytes, it also can increase the fatty acid oxidation and suppressed lipid accumulation in 3T3-L1 adipocytes. Raspberry ketone has anti-melanogenic activity, it could be used to treat hyperpigmentation. Raspberry ketone enhances the differentiation of C3H10T1/2 stem cells into osteoblasts, and it may promote bone formation by an action unrelated to adipocyte differentiation. |
| CFN93228 | Raspberryketone glucoside Raspberry ketone glucoside has lasting effects for the inhibition of melanogenesis and various melanogenic factors after the degradation in the skin. |
| CFN92605 | RA-V RA-V is an potential anti-angiogenic agent, exhibits anti-angiogenic activities in HUVEC and HMEC-1 cell lines with changes in function of these endothelial cells. RA-V also has anti-cancer activity, is a potential anti-metastatic agent in breast cancer, and likely acts via PI3K/AKT and NF-κB signaling pathways in both ER-positive and ER-negative breast cancer cells. |
